Harbin Medisan Pharmaceutical Co., Ltd.
SZSE:002900.SZ
12.44 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 73.663 | 26.503 | 349.678 | 26.633 | 173.86 | 204.387 | 181.076 | 175.183 | 166.301 | 146.984 | 104.394 | 82.717 |
| Afschrijvingen & Amortisatie
| 114.025 | 106.568 | 99.132 | 79.947 | 78.992 | 73.808 | 68.804 | 57.78 | 47.179 | 36.21 | 10.396 | 9.089 |
| Uitgestelde Inkomstenbelasting
| 0 | 11.697 | 95.02 | -1.442 | 7.206 | 4.674 | 1.169 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 8.143 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.583 | 0 |
| Verandering in Werkkapitaal
| -104.966 | 49.488 | 107.424 | -160.097 | 76.117 | 41.62 | -9.179 | -13.586 | -10.246 | -74.091 | 0 | 0 |
| Vorderingen
| -6.742 | -10.026 | 49.608 | 49.088 | -59.009 | -67.261 | -86.083 | -17.867 | 0 | 0 | 0 | 0 |
| Voorraden
| -46.801 | 0.623 | 26.487 | 31.873 | -33.637 | -39.04 | -59.962 | 13.746 | 0.855 | -4.643 | 0 | 0 |
| Crediteuren
| -51.423 | 47.193 | -63.691 | -239.616 | 161.558 | 143.247 | 135.696 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -0 | 11.697 | 95.02 | -1.442 | 7.206 | 80.66 | 50.783 | -27.332 | -11.101 | -69.448 | 0 | 0 |
| Overige Niet-Contante Posten
| -47.029 | -37.917 | -568.767 | 49.01 | -8.829 | -27.357 | -17.242 | 11.807 | -2.385 | 7.209 | -104.394 | -82.717 |
| Kasstroom uit Operationele Activiteiten
| 35.694 | 144.642 | -12.534 | -4.507 | 320.141 | 292.458 | 223.458 | 231.183 | 200.85 | 116.311 | 167.099 | 123.218 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -299.579 | -89.224 | -73.949 | -145.855 | -198.633 | -78.412 | -104.928 | -93.877 | -141.718 | -145.81 | -154.126 | -91.008 |
| Netto Overnames
| -15.98 | 0.27 | 11.614 | 146.439 | 199.374 | 0 | 104.993 | 0.079 | -0.5 | 8.4 | -0.5 | -5.733 |
| Aankoop van Beleggingen
| -60.432 | -72 | -1,113.735 | -1,091.007 | -2,271.01 | -2,482.086 | -655 | -14 | 0 | 0 | -19.88 | -40 |
| Verkoop/verval van Beleggingen
| 107.126 | 580.207 | 901.889 | 1,437.568 | 2,340.926 | 2,399.471 | 34.552 | 0 | 0 | 0 | 0.117 | 40.118 |
| Overige Investeringsactiviteiten
| 8.341 | 0 | -4.053 | -145.855 | -198.633 | 0.557 | -104.928 | 0.079 | 0.031 | 1.344 | -0.133 | 0.128 |
| Kasstroom uit Investeringsactiviteiten
| -260.523 | 419.253 | -278.234 | 201.291 | -127.977 | -160.47 | -725.31 | -107.797 | -142.187 | -136.066 | -174.522 | -96.495 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 37.534 | 156.256 | 189.14 | 89.507 | 122 | 0 | 0 | 0 | -17 | -20 | 55 | 20 |
| Uitgifte van Gewone Aandelen
| 0 | 47.291 | 0 | 0 | 85.774 | 0 | -12.071 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -1.17 | 0 | 0 | 0 | -85.774 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -41.037 | -99.131 | -24.783 | -86.74 | -202.533 | -107.452 | -92.372 | -91.39 | -54.02 | -52.504 | -41.956 | -4.673 |
| Overige Financieringsactiviteiten
| -10.409 | -154.039 | -208.065 | 3.728 | -97.562 | 79.841 | 813.688 | 28.574 | 1.921 | 103.087 | -5.708 | -0.36 |
| Kasstroom uit Financieringsactiviteiten
| -15.082 | -107.121 | -43.708 | -2.557 | -178.095 | -27.611 | 721.316 | -66.406 | -69.099 | 30.583 | 7.336 | 14.967 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -239.911 | 456.774 | -334.475 | 194.227 | 14.069 | 104.377 | 219.465 | 56.98 | -10.436 | 10.828 | -0.087 | 41.69 |
| Kaspositie aan het Einde van de Periode
| 542.358 | 782.27 | 325.496 | 659.972 | 465.744 | 451.675 | 347.298 | 127.833 | 70.853 | 81.289 | 70.462 | 70.549 |